Pricing Log in Create free account

Innate Pharma S.A. Sponsored ADR (IPHA) vs MediWound Ltd. (MDWD)

Innate Pharma S.A. Sponsored ADR and MediWound Ltd. are both Biotechnology companies. Innate Pharma S.A. Sponsored ADR and MediWound Ltd. are of similar size ($165.3M and $157.6M). Innate Pharma S.A. Sponsored ADR grew revenue faster over the last twelve months: −4.17% against −40.3%. Innate Pharma S.A. Sponsored ADR has the higher net margin (−99.7% vs −170.1%) and the higher return on invested capital (0.00% vs −6,551.8%). Across the 16 metrics below, Innate Pharma S.A. Sponsored ADR leads on 11 and MediWound Ltd. on 5.

Valuation

Metric IPHA MDWD Biotechnology median
P/E n/m n/m 8.50
P/S n/m 12.87 9.71
P/B n/m 4.28 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.12 9.97 9.21
Earnings yield (81.58%) (13.50%) (33.15%)
Free cash flow yield 0.00% (18.71%) (25.50%)

Profitability

Metric IPHA MDWD Biotechnology median
Gross margin 0.00% 15.46% 65.16%
Operating margin 0.00% (267.75%) 0.00%
Net margin (99.70%) (170.10%) 0.00%
Free cash flow margin 0.00% (240.47%) 0.00%
Return on equity 0.00% (75.42%) (56.36%)
Return on assets 0.00% (29.06%) (48.04%)
Return on invested capital 0.00% (6,551.77%) 0.00%

Growth

Metric IPHA MDWD Biotechnology median
Revenue growth (TTM) (4.17%) (40.26%) 6.02%
EPS growth (last fiscal year) 6.06% 30.69% 30.26%
Revenue growth, 5-year CAGR (33.86%) (4.87%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IPHA MDWD Biotechnology median
Debt to equity (0.50) 0.00 0.00
Current ratio 0.60 2.32 4.72
Net debt to EBITDA 0.22 2.27 0.96

Dividend

Metric IPHA MDWD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IPHA MDWD Biotechnology median
Market cap 165.32m 157.63m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack